<VariationArchive VariationID="2703410" VariationName="NM_001040716.2(PC):c.3362_3363del (p.Ile1121fs)" VariationType="Deletion" Accession="VCV002703410" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2859701" VariationID="2703410">
      <GeneList>
        <Gene Symbol="PC" FullName="pyruvate carboxylase" GeneID="5091" HGNC_ID="HGNC:8636" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="66848420" stop="66958383" display_start="66848420" display_stop="66958383" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="66615996" stop="66725846" display_start="66615996" display_stop="66725846" Strand="-" />
          </Location>
          <OMIM>608786</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001040716.2(PC):c.3362_3363del (p.Ile1121fs)</Name>
      <CanonicalSPDI>NC_000011.10:66849072:TAT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="66849073" stop="66849074" display_start="66849073" display_stop="66849074" variantLength="2" positionVCF="66849072" referenceAlleleVCF="CTA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="66616544" stop="66616545" display_start="66616544" display_stop="66616545" variantLength="2" positionVCF="66616543" referenceAlleleVCF="CTA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>I1121fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.66849074_66849075del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.66849074_66849075del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.66616545_66616546del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.66616545_66616546del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008319.1" sequenceAccession="NG_008319" sequenceVersion="1" change="g.114303_114304del">
            <Expression>NG_008319.1:g.114303_114304del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000920.4" sequenceAccession="NM_000920" sequenceVersion="4" change="c.3362_3363del">
            <Expression>NM_000920.4:c.3362_3363del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000911.2" sequenceAccession="NP_000911" sequenceVersion="2" change="p.Ile1121fs">
            <Expression>NP_000911.2:p.Ile1121fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001040716.2" sequenceAccession="NM_001040716" sequenceVersion="2" change="c.3362_3363del" MANESelect="true">
            <Expression>NM_001040716.2:c.3362_3363del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035806.1" sequenceAccession="NP_001035806" sequenceVersion="1" change="p.Ile1121fs">
            <Expression>NP_001035806.1:p.Ile1121fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022172.3" sequenceAccession="NM_022172" sequenceVersion="3" change="c.3362_3363del">
            <Expression>NM_022172.3:c.3362_3363del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_071504.2" sequenceAccession="NP_071504" sequenceVersion="2" change="p.Ile1121fs">
            <Expression>NP_071504.2:p.Ile1121fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001040716.2(PC):c.3362_3363del (p.Ile1121fs) AND Pyruvate carboxylase deficiency" Accession="RCV003498807" Version="1">
        <ClassifiedConditionList TraitSetID="532">
          <ClassifiedCondition DB="MedGen" ID="C0034341">Pyruvate carboxylase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18676167</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23430542</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="532" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5842" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Pyruvate Carboxylase Deficiency Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATAXIA WITH LACTIC ACIDOSIS II</ElementValue>
                <XRef Type="MIM" ID="266150" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pyruvate carboxylase deficiency</ElementValue>
                <XRef ID="Pyruvate+carboxylase+deficiency/6120" DB="Genetic Alliance" />
                <XRef ID="87694001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PC deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia with lactic acidosis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leigh necrotizing encephalopathy due to pyruvate carboxylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leigh syndrome due to pyruvate carboxylase deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Pyruvate carboxylase (PC) deficiency is characterized in most affected individuals by failure to thrive, developmental delay, recurrent seizures, and metabolic acidosis. Three clinical types are recognized: Type A (infantile form), in which most affected children die in infancy or early childhood. Type B (severe neonatal form), in which affected infants have hepatomegaly, pyramidal tract signs, and abnormal movement and die within the first three months of life. Type C (intermittent/benign form), in which affected individuals have normal or mildly delayed neurologic development and episodic metabolic acidosis.</Attribute>
                <XRef ID="NBK6852" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7512" />
                <XRef ID="7512" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301764</ID>
                <ID Source="BookShelf">NBK6852</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, ACT Sheet, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrullinemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, [Elevated Citrulline], Amino Acidemia/Urea Cycle Disorder, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrulline-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Elevated Citrulline: Amino Acidemia Algorithm, 2022</CitationText>
              </Citation>
              <XRef ID="3008" DB="Orphanet" />
              <XRef ID="C0034341" DB="MedGen" />
              <XRef ID="MONDO:0009949" DB="MONDO" />
              <XRef Type="MIM" ID="266150" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8050828" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="30368982|MedGen:C0034341" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004365332" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18676167</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23430542</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ile1121Argfs*50) in the PC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 58 amino acid(s) of the PC protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PC-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant disrupts a region of the PC protein in which other variant(s) (p.Leu1137Valfs*34) have been determined to be pathogenic (PMID: 18676167, 23430542). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.66616544_66616545del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0034341" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8050828" TraitType="Disease" MappingType="XRef" MappingValue="C0034341" MappingRef="MedGen">
        <MedGen CUI="C0034341" Name="Pyruvate carboxylase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

